Search alternatives:
significant colocalization » significant complication (Expand Search), significant neutralization (Expand Search), significant association (Expand Search)
colocalization result » localization results (Expand Search), localization recall (Expand Search)
point decrease » point increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant colocalization » significant complication (Expand Search), significant neutralization (Expand Search), significant association (Expand Search)
colocalization result » localization results (Expand Search), localization recall (Expand Search)
point decrease » point increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Table_2_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV
Published 2024“…</p>Results<p>Elevated cathepsin B levels were associated with a decreased risk of PD in univariate MR analysis (odds ratio [OR] = 0.890, 95% confidence interval [CI]: 0.831–0.954, pFDR = 0.009). …”
-
8
Image_2_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.PDF
Published 2024“…</p>Results<p>Elevated cathepsin B levels were associated with a decreased risk of PD in univariate MR analysis (odds ratio [OR] = 0.890, 95% confidence interval [CI]: 0.831–0.954, pFDR = 0.009). …”
-
9
Table_1_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.DOCX
Published 2024“…</p>Results<p>Elevated cathepsin B levels were associated with a decreased risk of PD in univariate MR analysis (odds ratio [OR] = 0.890, 95% confidence interval [CI]: 0.831–0.954, pFDR = 0.009). …”
-
10
Table_7_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV
Published 2024“…</p>Results<p>Elevated cathepsin B levels were associated with a decreased risk of PD in univariate MR analysis (odds ratio [OR] = 0.890, 95% confidence interval [CI]: 0.831–0.954, pFDR = 0.009). …”
-
11
Table_5_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV
Published 2024“…</p>Results<p>Elevated cathepsin B levels were associated with a decreased risk of PD in univariate MR analysis (odds ratio [OR] = 0.890, 95% confidence interval [CI]: 0.831–0.954, pFDR = 0.009). …”
-
12
Table_4_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV
Published 2024“…</p>Results<p>Elevated cathepsin B levels were associated with a decreased risk of PD in univariate MR analysis (odds ratio [OR] = 0.890, 95% confidence interval [CI]: 0.831–0.954, pFDR = 0.009). …”
-
13
Table_6_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV
Published 2024“…</p>Results<p>Elevated cathepsin B levels were associated with a decreased risk of PD in univariate MR analysis (odds ratio [OR] = 0.890, 95% confidence interval [CI]: 0.831–0.954, pFDR = 0.009). …”
-
14
Image_1_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.PDF
Published 2024“…</p>Results<p>Elevated cathepsin B levels were associated with a decreased risk of PD in univariate MR analysis (odds ratio [OR] = 0.890, 95% confidence interval [CI]: 0.831–0.954, pFDR = 0.009). …”
-
15
Table_3_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV
Published 2024“…</p>Results<p>Elevated cathepsin B levels were associated with a decreased risk of PD in univariate MR analysis (odds ratio [OR] = 0.890, 95% confidence interval [CI]: 0.831–0.954, pFDR = 0.009). …”